Source: International Business Times
As compute power reshapes the pharmaceutical industry, it simultaneously forces a reckoning with the structural and ethical guardrails needed to govern such a powerful force. Reuters As AI bolsters the drug discovery pipeline, the boundaries of pharmaceuticals and technology are becoming increasingly blurred. Pharmaceutical giant Eli Lilly's unveiling earlier this year of its supercomputer LillyPod, developed in partnership with NVIDIA, epitomizes this evolution.
Aller á la Source
Nouvelles connexes
